Wedbush Securities’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-5,902
| Closed | -$245K | – | 1157 |
|
|
2024
Q4 | $245K | Buy |
5,902
+1,686
| +40% | +$70K | 0.01% | 929 |
|
|
2024
Q3 | $282K | Sell |
4,216
-17
| -0.4% | -$1.14K | 0.01% | 830 |
|
|
2024
Q2 | $503K | Sell |
4,233
-382
| -8% | -$45.4K | 0.02% | 625 |
|
|
2024
Q1 | $492K | Sell |
4,615
-1,264
| -22% | -$135K | 0.02% | 645 |
|
|
2023
Q4 | $585K | Buy |
5,879
+241
| +4% | +$24K | 0.03% | 502 |
|
|
2023
Q3 | $582K | Sell |
5,638
-265
| -4% | -$27.4K | 0.03% | 469 |
|
|
2023
Q2 | $717K | Buy |
5,903
+110
| +2% | +$13.4K | 0.03% | 420 |
|
|
2023
Q1 | $890K | Sell |
5,793
-11
| -0.2% | -$1.69K | 0.04% | 351 |
|
|
2022
Q4 | $1.04M | Sell |
5,804
-241
| -4% | -$43.3K | 0.06% | 293 |
|
|
2022
Q3 | $715K | Sell |
6,045
-422
| -7% | -$49.9K | 0.04% | 379 |
|
|
2022
Q2 | $924K | Sell |
6,467
-1,005
| -13% | -$144K | 0.05% | 313 |
|
|
2022
Q1 | $1.29M | Buy |
7,472
+392
| +6% | +$67.5K | 0.06% | 278 |
|
|
2021
Q4 | $1.8M | Buy |
7,080
+1,238
| +21% | +$314K | 0.08% | 209 |
|
|
2021
Q3 | $2.25M | Buy |
5,842
+422
| +8% | +$162K | 0.11% | 159 |
|
|
2021
Q2 | $1.27M | Sell |
5,420
-2,133
| -28% | -$501K | 0.06% | 302 |
|
|
2021
Q1 | $989K | Sell |
7,553
-4,200
| -36% | -$550K | 0.05% | 334 |
|
|
2020
Q4 | $1.23M | Buy |
11,753
+5,859
| +99% | +$612K | 0.11% | 201 |
|
|
2020
Q3 | $417K | Buy |
+5,894
| New | +$417K | 0.04% | 486 |
|